Lead: Northern Virginia is facing an intense influenza surge in early January, with the Virginia Department of Health reporting respiratory illnesses — driven largely by an influenza A subclade known as k — are responsible for 22% of emergency-room visits in the week ending Jan. 3. The outbreak has coincided with the December–February peak of the season and follows the development of the 2025 vaccine, which public health officials say did not anticipate this mutated subclade. Nationwide, the U.S. Centers for Disease Control and Prevention (CDC) estimates at least 11 million flu cases so far this season, with about 120,000 hospitalizations and 5,000 deaths. Health systems in Northern Virginia are expanding urgent-care capacity and telehealth hours to reduce emergency-department strain.
Key takeaways
- Virginia ER burden: Respiratory illnesses made up 22% of emergency-department visits in the week ending Jan. 3, according to the Virginia Department of Health.
- Dominant strain: A mutated influenza A subclade labeled k is the main driver of this season’s surge; it emerged after the 2025 vaccine formulation was finalized.
- National toll: The CDC estimates at least 11 million flu cases, roughly 120,000 hospitalizations and about 5,000 deaths nationwide this season.
- Geographic spread: The CDC reports flu activity rated high or very high in 48 states at the most recent update.
- Local response: Inova–GoHealth Urgent Care, operating 23 centers across Northern Virginia, has increased support staff and extended virtual visit hours to midnight.
- Clinical guidance: Clinicians advise urgent or primary care for routine testing and antivirals; emergency care is reserved for breathing trouble, chest pain, severe dehydration or altered mental status.
Background
The winter respiratory season traditionally peaks between December and February, when close indoor contact and holiday travel increase viral transmission. Seasonal vaccines are designed months in advance; the 2025 formulation was selected before some subsequent viral evolution produced the subclade now identified as a major driver of cases. Influenza A subclades can change surface proteins enough to reduce vaccine-match effectiveness, which complicates control efforts and can increase clinical burden.
Public-health surveillance combines reports from emergency departments, outpatient clinics and laboratory sequencing to identify circulating strains and severity. The CDC aggregates state-level reports to estimate national case counts, hospitalizations and deaths; those estimates are updated weekly as new data arrive. States including Virginia share more granular ER and outpatient percentages that help local systems adjust staffing and care pathways.
Main event
In Northern Virginia the spike in respiratory visits accelerated after holiday travel and gatherings, according to clinicians at local urgent-care centers. The Virginia Department of Health recorded that 22% of ER visits the week ending Jan. 3 were for respiratory complaints, a notable share that has pushed some outpatient clinics to alter schedules and expand telehealth. Clinicians report a preponderance of influenza A cases and say lab sequencing has identified a subclade labeled k as prevalent in regional samples.
Inova–GoHealth Urgent Care, a partnership between Inova and GoHealth that runs 23 centers in the region, has responded by increasing on-site support staff and lengthening virtual-visit hours until midnight to handle nonemergency cases and triage patients away from hospital emergency departments. The urgent-care network says the goal is to deliver early testing and antiviral treatment while preserving ER capacity for severe illness. Local hospitals have also reinforced mask policies in high-risk wards and stepped up internal staffing contingencies.
Clinicians describe typical influenza presentation in this wave as abrupt onset of high fever, body aches, cough and profound fatigue — an experience some patients liken to being “hit by a bus.” Providers emphasize that the first three days after symptom onset are when individuals tend to be most contagious and that early antiviral therapy can reduce complications if started promptly. For those with mild-to-moderate symptoms, primary care or urgent care clinics remain the recommended first stop for testing and treatment.
Analysis & implications
The emergence of an influenza A subclade after vaccine selection highlights an ongoing challenge for seasonal flu prevention: vaccine strain selection occurs months ahead of the season, leaving risk of mismatch if the virus evolves. A partial mismatch can still moderate illness in many people, but it may reduce vaccine effectiveness for preventing infection, increasing reliance on antivirals and nonpharmaceutical interventions to limit spread. For the 2025–26 season, that dynamic appears to have contributed to higher-than-usual outpatient and ER demand in some regions, including Northern Virginia.
Health-system strain is uneven: areas with high outpatient capacity and robust telehealth can manage more cases outside hospitals, while communities with limited access face greater ER burden. Inova–GoHealth’s expansion of virtual hours and staff is a local mitigation that can blunt ER surges, but those measures require funding, staffing and patient awareness to be effective. If high transmission persists, hospitals could see increases in admissions that strain ICU capacity and workforce availability, especially if staffing shortages arise from staff illness or burnout.
Economically, an active flu season raises absenteeism in schools, workplaces and essential services, with downstream effects on productivity and childcare availability. Public messaging emphasizing vaccination (even with partial match), early testing, antiviral access for high-risk individuals and routine hygiene can reduce peak pressure. Policymakers and health systems may weigh midseason investments — such as targeted vaccination drives, antiviral supply logistics and expanded urgent-care capacity — to blunt continuing spread.
Comparison & data
| Metric | U.S. (CDC estimate) | Virginia / Northern Virginia |
|---|---|---|
| Estimated cases | 11,000,000+ cases | Not publicly aggregated; regional ER share: 22% respiratory visits (week ending Jan. 3) |
| Hospitalizations | ~120,000 | Local hospitals reporting increased admissions; specific counts vary by facility |
| Deaths | ~5,000 | State-level reports updated periodically by VDH |
| Geographic spread | High/very high in 48 states | High activity reported across much of Virginia |
The table contextualizes national estimates reported by the CDC with specific system-level indicators available in Virginia. State and regional metrics are updated at different cadences; ER-percentage measures can shift week to week and are more sensitive to local health-seeking behavior and clinic capacity than broad national estimates.
Reactions & quotes
Local urgent-care leadership described operational changes and the clinical picture that drove them. The following excerpts capture clinician concerns and public-health rationale for diverting nonemergency patients to urgent-care and telehealth services.
“We are seeing very high acute respiratory illness levels across the region, and we’re trying to expand care options so emergency departments remain available for the sickest patients.”
Dr. Meredith Porter, medical director, Inova–GoHealth Urgent Care
Providers stressed practical steps for patients and the public to limit transmission and get appropriate care.
“We’re trying our best to avoid people going to the emergency room by increasing staff and extending virtual visits into the evening hours.”
Inova–GoHealth Urgent Care statement summarized by clinic leadership
Clinicians also offered everyday precautions for shoppers and commuters to reduce spread in public settings.
“If you’re standing in that checkout line, give yourself a bit of space — and consider a mask if you must be around others while symptomatic.”
Dr. Meredith Porter
Unconfirmed
- The precise degree to which the post-vaccine emergence of subclade k reduced vaccine effectiveness in Northern Virginia is still under investigation and has not yet been quantified in peer-reviewed analyses.
- Reports that statewide ER respiratory cases fell between the week ending Dec. 27 and the week ending Jan. 3 are based on clinician accounts and require confirmation from VDH surveillance tables for a definitive trend interpretation.
- Projections for how long high community transmission will persist depend on evolving viral behavior, vaccination uptake and public adherence to precautions; those longer-term forecasts remain uncertain.
Bottom line
Northern Virginia’s current surge is part of a broadly active U.S. influenza season that the CDC characterizes as widespread and severe in many states. The appearance of an influenza A subclade after vaccine selection has complicated control efforts, and local health systems are responding with expanded urgent-care access and telehealth to protect emergency departments for the most critical cases.
For individuals, early testing and prompt consultation with primary or urgent care are the most practical steps unless danger signs — severe shortness of breath, chest pain, dehydration or altered mental status — are present. Public-health emphasis on vaccination, hygiene, masking when symptomatic and staying home while contagious will remain the most effective community measures to reduce further spread and protect high-risk people.
Sources
- InsideNoVa — Local reporting on Northern Virginia flu surge (regional news)
- U.S. Centers for Disease Control and Prevention — FluView weekly surveillance (federal public-health surveillance)
- Virginia Department of Health — Epidemiology and surveillance (state health department)
- Inova Health System communications (health system)